Updated Jul 16, 2026
Kanter Stacy J. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $5K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-27 | OPY | OPPENHEIMER HOLDINGS INC | J — Other acquisition / disposition | 1.4K | — | |
| 2026-02-04 | APLT | Applied Therapeutics, Inc. | J — Other acquisition / disposition | 42.5K | — | |
| 2026-02-04 | APLT | Applied Therapeutics, Inc. | D — Derivative transaction | 22.5K | — | |
| 2025-12-18 | APLT | Applied Therapeutics, Inc. | S — Open-market sale | 43.0K | $0.11 | $5K |
Kanter Stacy J. is a corporate insider — currently tracked as Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($5K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kanter Stacy J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.